Eli Lilly and Company (LLY)

A Look at Eli Lilly and Co (LLY) After 1.4% Decline -- GF Value $1575.10 vs Price $1166.51

Here's Why Eli Lilly (LLY) Fell More Than Broader Market

Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Prediction: Eli Lilly Could Have More Room to Grow Than Its Valuation Suggests

Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff

Eli Lilly Reports Earnings on Oct. 29. Here's Why the Retatrutide Story Matters More Than the Quarter.

Eli Lilly and Company $LLY Stock Acquired by NorthCrest Asset Manangement LLC

Eli Lilly and Company $LLY Stock Purchased by Woodstock Corp

Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.

Will Eli Lilly Do a Stock Split Before the End of 2026?

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

Eli Lilly and Company (NYSE:LLY) Stock Keeps “Outperform” Rating at Royal Bank Of Canada

This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock

Top 50 High-Quality Dividend Growth Stocks For October 2026

Record Highs Beckon for Big Caps as Small Caps Lag and Deal Flow Builds

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

Eli Lilly's Biggest Shareholder Just Filed to Sell $347 Million of Stock

Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity